Related Experiment Videos

Effects of mexiletine on delayed after-depolarization and triggered activity

H Uchida1, E Ozawa, Y Watanabe

  • 1Cardiovascular Institute, Fujita Health University School of Medicine, Aichi, Japan.

Heart and Vessels
|January 1, 1990
PubMed

Insights

Mexiletine effectively suppressed delayed afterdepolarizations (DAD) and triggered activity (TA) in rabbit heart muscle. This antiarrhythmic effect was observed in 94% of preparations, suggesting mexiletine

Area of Science:

  • Cardiovascular Physiology
  • Pharmacology
  • Cardiac Electrophysiology

Background:

  • Delayed afterdepolarizations (DAD) and triggered activity (TA) are implicated in cardiac arrhythmias.
  • Induction of DAD and TA is dependent on specific ionic conditions and stimulation protocols.

Purpose of the Study:

  • To investigate the antiarrhythmic effects of mexiletine on DAD and TA in rabbit ventricular muscle.
  • To explore the underlying mechanisms of mexiletine's action.

Main Methods:

  • Rabbit ventricular muscle preparations were subjected to rapid stimulations under various perfusate conditions (modified Tyrode's, K(+)-free, low K(+)/high Ca2+).
  • Delayed afterdepolarizations (DAD) and triggered activity (TA) were induced using specific stimulation protocols (300 ms cycle length, trains of 10-20 stimuli).
  • The effects of mexiletine (5 mg/l) on DAD and TA were assessed, along with changes in electrophysiological parameters.

Main Results:

  • DAD and TA were most readily induced in low K(+) + high Ca2+ solution (83% inducibility).
  • Mexiletine completely suppressed DAD and TA in 94% of preparations within 20 minutes.
  • Mexiletine reduced DAD amplitude and prolonged coupling intervals, potentially by affecting intracellular calcium or ion currents.

Conclusions:

  • Mexiletine demonstrates significant efficacy in suppressing DAD and TA, key triggers for cardiac arrhythmias.
  • The drug's mechanism likely involves modulation of intracellular calcium handling and ion channel activity.
  • These findings support mexiletine's potential as an antiarrhythmic agent for conditions associated with DAD and TA.

Related Concept Videos